These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35141229)

  • 21. Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients.
    Shi R; Bao X; Unger K; Sun J; Lu S; Manapov F; Wang X; Belka C; Li M
    Theranostics; 2021; 11(10):5061-5076. PubMed ID: 33754044
    [No Abstract]   [Full Text] [Related]  

  • 22. Machine learning-based integration of CD8 T cell-related gene signatures for comprehensive prognostic assessment in lung adenocarcinoma.
    Yong J; Wang D; Yu H
    Transl Cancer Res; 2024 Jul; 13(7):3217-3241. PubMed ID: 39145093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.
    Gao X; Tang M; Tian S; Li J; Liu W
    Future Oncol; 2021 Apr; 17(12):1533-1544. PubMed ID: 33432837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a Three-Gene Signature Based on Epithelial-Mesenchymal Transition of Lung Adenocarcinoma Through Construction and Validation of a Risk-Prediction Model.
    Shi J; Wang Z; Guo J; Chen Y; Tong C; Tong J; Hu W; Li C; Li X
    Front Oncol; 2021; 11():726834. PubMed ID: 34745947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of an immune prognostic 11-gene signature for lung adenocarcinoma.
    Yang T; Hao L; Cui R; Liu H; Chen J; An J; Qi S; Li Z
    PeerJ; 2021; 9():e10749. PubMed ID: 33552736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A New Risk Score Model Based on Pyrogenic Signatures for the Prediction of Survival and Immune Microenvironment Features in Lung Adenocarcinoma.
    Zhao L; Wang L; Guo T; Gu C; Wang J
    Int J Gen Med; 2023; 16():2323-2336. PubMed ID: 37313044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X; Hu Z; Huang C; Chang J
    Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma.
    Zhang Y; Wang Y; Chen J; Xia Y; Huang Y
    Front Immunol; 2023; 14():1183230. PubMed ID: 37671155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of an epithelial-mesenchymal transition-related gene signature for predicting prognosis.
    Zhou DH; Du QC; Fu Z; Wang XY; Zhou L; Wang J; Hu CK; Liu S; Li JM; Ma ML; Yu H
    World J Clin Cases; 2022 Sep; 10(26):9285-9302. PubMed ID: 36159424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Clinical and Tumor Microenvironment Characteristics of Hypoxia-Related Risk Signature in Lung Adenocarcinoma.
    Dai Z; Liu T; Liu G; Deng Z; Yu P; Wang B; Cen B; Guo L; Zhang J
    Front Mol Biosci; 2021; 8():757421. PubMed ID: 34869590
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method.
    Ma B; Geng Y; Meng F; Yan G; Song F
    J Cancer; 2020; 11(5):1288-1298. PubMed ID: 31956375
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification and Validation of a Hypoxia and Glycolysis Prognostic Signatures in Lung Adenocarcinoma.
    Zhao W; Ding C; Zhao M; Li Y; Huang H; Li X; Cheng Q; Shi Z; Gao W; Liu H; Chen J
    J Cancer; 2024; 15(6):1568-1582. PubMed ID: 38370379
    [No Abstract]   [Full Text] [Related]  

  • 34. Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer.
    Cao L; Li T; Ba Y; Chen E; Yang J; Zhang H
    Front Genet; 2022; 13():801484. PubMed ID: 35281839
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
    Li C; Long Q; Zhang D; Li J; Zhang X
    BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
    Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q
    Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine learning developed a programmed cell death signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma.
    Ding D; Wang L; Zhang Y; Shi K; Shen Y
    Transl Oncol; 2023 Dec; 38():101784. PubMed ID: 37722290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma.
    Jiang H; Xu S; Chen C
    BMC Cancer; 2020 Aug; 20(1):782. PubMed ID: 32819300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.